DHR vs EOLS · P/E 39, rev $24.57B vs rev $266.3M
Danaher Corporation (DHR) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the DHR and EOLS stock pages for the full models.
Not investment advice.